Nuvectis Pharma Target Price

Where could NVCT trade next? Consensus target price: $31.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.07

Average Target Price

$31.25

48.3% upside

4 analysts in the last 4 months

High: $40 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-01	Loop Capital MarketsElemer Piros	$40	89.8% upside
2026-07-06	UBS	$33	56.6% upside
2026-06-22	H.C. Wainwright	$39	85.1% upside
2026-06-12	H.C. Wainwright	$13	38.3% downside
2025-08-04	H.C. Wainwright	$10	52.5% downside

Nuvectis Pharma (NVCT) FAQ

The latest target price for NVCT is $31. Investors often review this figure alongside Nuvectis Pharma's historical trend and sector peers before judging valuation or financial health.

Nuvectis Pharma trades near $21.07 while the consensus target sits at $31 (48.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting NVCT's target price ($31), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.